Anti-tumor effects of dovitinib in patient-derived gastrointestinal stromal tumor (GIST) xenograft models
Autor: | Jasmien Cornillie, Haifu Li, Lise Vreys, Yemarshet K. Gebreyohannes, Patrick Schöffski, Maria Debiec-Rychter, Ana-Maria Rodriguez, Thomas Van Looy, Agnieszka Wozniak, Ulla Vanleeuw, Raf Sciot, Jasmien Wellens, Matthew Squires |
---|---|
Rok vydání: | 2015 |
Předmět: |
Antitumor activity
Cancer Research Pathology medicine.medical_specialty GiST Sunitinib business.industry Imatinib urologic and male genital diseases female genital diseases and pregnancy complications digestive system diseases chemistry.chemical_compound Oncology chemistry hemic and lymphatic diseases Regorafenib Cancer research medicine In patient Stromal tumor business neoplasms Tyrosine kinase medicine.drug |
Zdroj: | Journal of Clinical Oncology. 33:10532-10532 |
ISSN: | 1527-7755 0732-183X |
Popis: | 10532 Background: Advanced GIST is treated with the tyrosine kinase inhibitors imatinib, sunitinib and regorafenib, but the majority of patients develop heterogeneous resistance to these agents. In... |
Databáze: | OpenAIRE |
Externí odkaz: |